This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hanon, S. Articles by Le Jemtel, T. H Search for Related Content PubMed PubMed Citation Articles by Hanon, S. Articles by Le Jemtel, T. H Social Bookmarking                         What's this?

Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure

The Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA

Pugazhendi Vijayaraman

The Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA

Edmund H Sonnenblick

The Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA

Thierry H Le Jemtel

The Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, lejemtel{at}aecom.yu.edu

Key Words: ACE inhibition • AT1-receptor antagonist • chronic heart failure

References

• The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.[Abstract]
• The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.[Abstract]
• Pfeffer MM, Braunwald E., Moye Lemuel A. et al. On Behalf of the SAVE Investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.[Abstract]
• Rousseau MF, Konstam MA, Benedict Claude R. et al. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol 1994;73:488-93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• MacFadyen RJ, Lee AF, Morton JJ, Pringle SD, Struthers AD: How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart 1999;82(1):57-61.[Abstract/Free Full Text]
• Van den Meiracker AH, Man in `t Veld, PJ, Ritesma van Eck HJ, BoomsmaF, Derkx FH, Schalekamp. MA Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992; 10(8):803-12.[Web of Science][Medline] [Order article via Infotrieve]
• Brunner-La Rocca HP, Vaddadi Gautm, Esler MD Recent insight into therapy of congestive heart failure: Focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol 1993;33:1163-73.[CrossRef]
• Pitt Bertram, Poole-Wilson P., Segal R. et al. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the losartan heart failure survival study-Elite II. J Cardiac Failure 1999;5:146-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pitt B., Poole-Wilson P., Segal R. et al. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure - Elite II. Lancet 2000 (In press).
• Christen Y. Waeber B., Nussberger J. et al. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers: inhibition of pressor response to exogenous angiotensin I and II. Circulation 1991; 83:1333-42.[Abstract/Free Full Text]
• Hamroff G., Katz SD, Mancini D. et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 1999;99:990-2.[Abstract/Free Full Text]
• Baruch L.,Anand I., Cohen IS, Ziesche S., Judd D., Cohn JN For the Vasodilator Heart Failure Trial (V-Heft) study Group: Augmented short - and long term haemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Circulation 1999;99:2658-64.[Abstract/Free Full Text]
• Benard J., Campbell DJ, Azizi M., Gonzales MF Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997;96:3072-8.[Abstract/Free Full Text]
• Azizi Michel, M.D., Chatellier Gilles, M.D., MSc; Guyene Thanh-Tam, M.D., Murieta-Geoffroy Dalia, M.D., Menard Joel, M.D. Circ 1995;92:825-34.[Abstract/Free Full Text]
• McKelvie RS, Yusuf S., Pericak et al. Comparision of candesartan, enalapril, and their combination in congestive heart failure: randomised evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 1999;100:1056-64.[Abstract/Free Full Text]
• Murdoch DR, McDonagh TA, Byrne J. et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomised comparison of the haemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1990;138(6): 1126-32.[CrossRef]
• Jorde UP, Ennezat PV, Lisker J. et al. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Circulation 2000;101(8):844-6.[Abstract/Free Full Text]
• Dell'Italia LJ, Meng QC, Balcells E. et al. Compartmentalization of angiotensin II generation in the dog heart: evidence for independent mechanisms in intravascular and interstitial spaces.J Clin Invest 1997;100:253-8.[Web of Science][Medline] [Order article via Infotrieve]
• Muller P., Cohen T., DeGasparo M., Sioufi A., Racine-Poon A., Howald H. Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. Eur J Clin Pharmacol 1994;47:231-45.[Web of Science][Medline] [Order article via Infotrieve]
• Wollert Kai C., Studer Roland, Bodil von Bulow BS, Drexler H. Survival after myocardial infarction in the rat-role of tissue angiotensin-converting enzyme inhibition. Circulation 1994;90:2457-67.[Abstract/Free Full Text]
• Roig E., Perez-Villa F., Morales M. et al. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur Heart J 2000;21(1):53-7.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 2, 147-150 (2000)
DOI: 10.3317/jraas.2000.018


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hanon, S. Articles by Le Jemtel, T. H Search for Related Content PubMed PubMed Citation Articles by Hanon, S. Articles by Le Jemtel, T. H Social Bookmarking                         What's this?